De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
GlaxoSmithKline Pharmaceuticals Dividend
Dividend criteriumcontroles 3/6
GlaxoSmithKline Pharmaceuticals is een dividendbetalend bedrijf met een huidig rendement van 1.17%.
Belangrijke informatie
1.2%
Dividendrendement
92%
Uitbetalingsratio
| Gemiddelde opbrengst industrie | 0.6% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | ₹32.000 |
| Winst per aandeel | ₹37.78 |
| Dividendrendementsvoorspelling | 1.2% |
Recente dividendupdates
Recent updates
We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Can Manage Its Debt With Ease
Aug 29
The GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 05Investors Appear Satisfied With GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Prospects As Shares Rocket 26%
Jun 01With EPS Growth And More, GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Makes An Interesting Case
May 05GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Popularity With Investors Is Clear
Apr 14Revenue Miss: GlaxoSmithKline Pharmaceuticals Limited Fell 5.9% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 15Is Now The Time To Put GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) On Your Watchlist?
Jan 18GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Investors Are Less Pessimistic Than Expected
Dec 28Here's Why We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Might Deserve Your Attention Today
Oct 05Is GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Using Too Much Debt?
Sep 12GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Has A Pretty Healthy Balance Sheet
Mar 17Does GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Have A Healthy Balance Sheet?
Sep 02GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Seems To Use Debt Rather Sparingly
Mar 02The GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Share Price Is Up 32% And Shareholders Are Holding On
Mar 20Does GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Have A Place In Your Dividend Portfolio?
Feb 27Declining Stock and Decent Financials: Is The Market Wrong About GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)?
Feb 06What Type Of Shareholders Make Up GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Share Registry?
Jan 11
GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Shareholders Have Enjoyed A 26% Share Price Gain
Dec 06Earnings Miss: GlaxoSmithKline Pharmaceuticals Limited Missed EPS By 48% And Analysts Are Revising Their Forecasts
Nov 01Tread With Caution Around GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) 1.3% Dividend Yield
Oct 29What Kind Of Shareholders Hold The Majority In GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Shares?
Sep 29If You Had Bought GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Stock A Year Ago, You Could Pocket A 30% Gain Today
Aug 30Is GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Recent Performancer Underpinned By Weak Financials?
Aug 02It Might Not Be A Great Idea To Buy GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) For Its Next Dividend
Jul 12Is GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) At Risk Of Cutting Its Dividend?
Jul 07Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: De dividendbetalingen van GLAXO zijn de afgelopen 10 jaar volatiel geweest.
Groeiend dividend: De dividendbetalingen van GLAXO zijn de afgelopen 10 jaar gestegen.
Dividendrendement versus markt
| GlaxoSmithKline Pharmaceuticals Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (GLAXO) | 1.2% |
| Markt onderkant 25% (IN) | 0.2% |
| Markt Top 25% (IN) | 1.1% |
| Gemiddelde industrie (Pharmaceuticals) | 0.6% |
| Analist prognose (GLAXO) (tot 3 jaar) | 1.2% |
Opmerkelijk dividend: Het dividend van GLAXO ( 1.17% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de Indian markt ( 0.24% ).
Hoog dividend: Het dividend van GLAXO ( 1.17% ) behoort tot de top 25% van dividendbetalers in de Indian markt ( 1.04% )
Winstuitkering aan aandeelhouders
Verdiendekking: Gezien de hoge payout ratio ( 91.9% ) worden de dividendbetalingen van GLAXO niet goed gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Gezien de hoge cash payout ratio ( 98.4% ) worden de dividendbetalingen van GLAXO niet goed gedekt door de kasstromen.